Quelles actions mettre en œuvre pour accroître la collecte de plasma à l'EFS ?

The need of plasma derivatives increases in France. The Établissement français du sang (EFS) carries out plans for supplying plasma to the Laboratoire français du fractionnement et des biotechnologies (LFB). Different kinds of actions are taken or will be taken according to the way of plasma processing. For plasma issued from whole blood, the increase is correlated with the increase of whole blood collection for the patients' need of red cells concentrates and the optimized plasma volume of plasma concentrate. For plasma issued from combined aphaeresis and the production of pooled platelets concentrates, synthetic media is favoured. Plasma aphaeresis is a specific way to satisfy requirements of the LFB. Communication choice of the blood collection's place, effects of the new law on blood donors selection, the process of aphaeresis collection, blood tests qualification are subjects of study and actions.